Results: For the CHSS Critical Left Ventricular Outflow Tract Study (LVOTO) study, for the Norwood procedure, completeness of enrollment at centers actively participating in the LVOTO study was 34%. For the Norwood operation, discharge mortality was 15% among 227 enrolled patients and 16% among 1768 nonenrolled potentially eligible patients from the 40 consenting institutions. Median postoperative length of stay was 31 days and 26 days for these enrolled and nonenrolled patients. For the CHSS anomalous aortic origin of a coronary artery (AAOCA) study, for AAOCA repair, completeness of enrollment at centers actively participating in the AAOCA study was 40%. Conclusion: Determination of the denominator of patients eligible for CHSS studies and comparison of ''eligible and enrolled patients'' to ''potentially eligible and not enrolled patients'' provides an estimate of the extent to which patients in CHSS studies are representative of the overall population of eligible patients; however, opportunities exist to improve enrollment.
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Background
This article is the second in a series of two articles that report the findings of a research project titled: ''Linking the Congenital Heart Surgery Database of the Society of Thoracic Surgeons (STS) with the Congenital Heart Surgeons' Society (CHSS) Database.'' The first article described the rationale and methodology of the STS-CHSS Link. 1 This second article describes the results of the analysis and summarizes the lessons learned to date from the STS-CHSS Link and their implications.
As described previously, 1 a link has been created between The Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) and The Congenital Heart Surgeons' Society Database (CHSS-D). Five matrices have been created that facilitate the automated identification within the STS-CHSD of patients who are potentially eligible for enrollment in each of the five active CHSS studies. As a result of a manual adjudication process and the refinement of the matrices, 1 the sensitivity of the matrices increased from 93% to 100% and the specificity increased from 94% to 98%. The purpose of this article is to report how the STS-CHSS Link is used to (1) estimate the denominator of patients who are potentially eligible for CHSS studies, (2) estimate the completeness of enrollment of patients eligible for CHSS studies among all CHSS sites, (3) estimate the completeness of enrollment of patients eligible for CHSS studies among those CHSS institutions participating in each CHSS cohort study, and (4) compare ''eligible and enrolled patients'' to ''eligible and not enrolled patients'' to assess the generalizability of CHSS studies.
Materials and Methods

STS-CHSS Link
The development, refinement, and verification of the five matrices that link the CHSS-D to the STS-CHSD have been described previously. 1 The processes of identification and recruitment of 40 centers that participate in both the STS-CHSD and the CHSS have also been described previously. 1 
Estimation of the Denominator of Patients Eligible for CHSS Studies
The five matrices were applied to the STS-CHSD at all 40 consenting institutions. In order to arrive at an estimate the denominator of surgical patients who are potentially eligible for CHSS studies, we determined the number of patients who fit into each of the following three groups for the primary procedures most commonly performed in patients enrolled in each of the four active CHSS studies with suitable enrollment (for the CHSS study of unbalanced atrioventricular septal defect [uAVSD], enrollment has only recently begun at the time of this project; and therefore, we simply report the number of patients identified by the matrix in its five most common primary procedures. This strategy is utilized because the uAVSD study does not yet have suitable enrollment for inclusion in other analyses in this article): 
Estimation of the Completeness of Enrollment of Patients Eligible for CHSS Studies
In our analysis, the term completeness is used to refer to the completeness of capture of potentially eligible patients (ie, the rate of enrollment of potentially eligible patients); this definition of completeness has been published previously. 2 Completeness of enrollment is calculated for each of the four active CHSS studies with suitable enrollment. Completeness of enrollment was defined as the number of actually enrolled patients divided by the number of patients identified as being eligible for enrollment. For the CHSS study of uAVSD, enrollment has only recently begun at the time of this project. Therefore, for the uAVSD study, we simply reported the number of patients identified by the matrix in its five most common primary procedures and we do not calculate completeness of enrollment. Two types of completeness are estimated:
1. completeness at centers actively enrolling patients in a given study (completeness at actively participating centers); and 2. completeness of enrollment among the entire cohort of 40 centers participating in this project (completeness at all potential centers).
The numerator for calculation of completeness at actively participating centers is all patients in group 1. The denominator for calculation of completeness at actively participating centers is the sum of all patients in groups 1 and 2.
The numerator for calculation of completeness at all potential centers is all patients in group 1. The denominator for calculation of completeness all potential centers is the sum of all patients in groups 1 and 3.
Comparison of Eligible and Enrolled Patients to Potentially Eligible and Not Enrolled Patients
This analysis is limited to the four active CHSS studies with suitable enrollment (The CHSS study of uAVSD has only recently begun enrollment at the time of this project; and therefore, this cohort is not included in this analysis of representativeness). For this analysis of representativeness, the four matrices specifically pertaining to the active CHSS studies with suitable enrollment were applied to all centers in the STS-CHSD. In order to facilitate estimation of the representativeness of patients enrolled in the CHSS studies, we performed an analysis in each of the following six groups of the two most commonly performed primary procedures among patients enrolled in each of these four active CHSS studies where suitable enrollment has occurred. a. Group A-enrolled patients associated with the 40 consenting CHSS institutions. b. Group B-nonenrolled potentially eligible patients associated with the 40 consenting CHSS institutions who also had an enrolled patient found in group A.
c. Group C-nonenrolled potentially eligible patients associated with all 40 consenting CHSS institutions regardless of them having or not having an enrolled patient (nb: group B is a subset of group C). d. Group D-potentially eligible patients associated with the 30 CHSS institutions which did not agree to participate. This is a subset of group E. e. Group E-potentially eligible patients associated with both the 30 CHSS institutions which did not agree to participant and all STS institutions which are not CHSS sites. f. Group F-all nonenrolled patients who met the inclusion criteria. This consists of group C and group E patients.
The matrices were applied to all participants in the STS-CHSD to identify patients who underwent frequently performed operations and compare ''eligible and enrolled patients'' to ''potentially eligible and not enrolled patients'' in following five domains: (1) age at surgery, (2) gender, (3) race, (4) discharge mortality, and (5) postoperative length of stay.
Institutional Review Board Approval
The Duke University Health System Institutional Review Board approved the study and provided a waiver of informed consent. Although the STS data used in the analysis contain patient identifiers, they were originally collected for nonresearch purposes and the risk to patients was deemed to be minimal. 3 This article was reviewed and approved by the STS-CHSD Access and Publications Committee. This article was also reviewed and approved by the CHSS Committee on Quality Improvement and Outcomes. Table 1 documents the number of patients in groups A through C for each of the four active CHSS studies with suitable enrollment. For the CHSS study of uAVSD, Table 1 also documents the number of patients identified by the matrix in its five most common primary procedures (group C only). Table 2 documents estimated completeness of enrollment at centers actively participating in a given CHSS study and at 40 CHSS centers that could potentially enroll patients.
Results
Estimation of the Denominator of Patients Eligible for CHSS Studies
Estimation of the Completeness of Enrollment of Patients Eligible for CHSS Studies
For the Tricuspid Atresia (TA) study, for modified Blalock-Taussig shunt (MBTS), completeness at actively participating centers was 30% and completeness at all potential centers was 12%. For the pulmonary conduit (PC) study, for truncus arteriosus repair, completeness at actively participating centers was 29% and completeness at all potential centers was 10%. For the Critical left ventricular outflow tract obstruction (LVOTO) study, for Norwood procedure, completeness at actively participating centers was 34% and completeness at all potential centers was 11%. For the anomalous aortic origin of a coronary artery (AAOCA) study, for AAOCA repair, completeness at actively participating centers was 40% and completeness at all potential centers was 12%.
Comparison of Eligible and Enrolled Patients to Eligible and Not Enrolled Patients
Data pertaining to the potential extent of representativeness of CHSS data for the two most common operations in each of the four active CHSS studies with suitable enrollment are provided in Tables 3 to 10 . For the TA study, we report data on the following two operations:
1. Primary procedure, 1590 ¼ Shunt, Systemic-topulmonary, MBTS 2. Primary procedure, 1640 ¼ Pulmonary artery banding (PAB)
For the PC study, we report data on the following two operations:
1. Primary procedure, 230 ¼ Truncus arteriosus repair 2. Primary procedure, 380 ¼ Tetralogy of Fallot repair, Right ventricle-to-pulmonary artery conduit
For the critical LVOTO study, we report data on the following two operations:
1. Primary procedure, 870 ¼ Norwood procedure 2. Primary procedure, 1640 ¼ PAB For the AAOCA study, we report data on the following two operations:
1. Primary procedure, 1305 ¼ AAOCA repair 2. Primary procedure, 1310 ¼ Coronary artery procedure, Other
As a representative example of these data, for the Norwood Operation, discharge mortality was 15% among 227 enrolled patients and 16% among 1768 nonenrolled potentially eligible patients from the 40 consenting institutions. Median postoperative length of stay was 31 days and 26 days for these enrolled and nonenrolled patients.
Discussion
This article is the second in a series of two articles describing the results of the STS-CHSS Link. This first article described the rationale and methodology of the STS-CHSS Link. This second article describes the type of data that can be provided in feedback reports to centers participating in both the STS-CHSD and the CHSS-D and discusses some of the lessons learned to date from the STS-CHSS Link and the implications of this analysis.
The STS-CHSS Link allows estimation of the penetration, completeness, and representativeness of the data in the CHSS-D. 2 In 2013, STS-CHSD contains data from 117 of the 125 hospitals with pediatric heart surgery programs (93.6% penetrance by hospital) in the United States and 3 of the 8 centers with pediatric heart surgery programs in Canada. [4] [5] [6] The CHSS includes 74 institutions from the United States and Canada, corresponding to a penetration of 55.6% of the 133 hospitals in the United States and Canada that perform pediatric and congenital heart surgery. Completeness of enrollment in CHSS studies at centers actively participating in these studies ranged from 29% to 40% across CHSS studies. For the most common operations performed on patients who enrolled in the CHSS cohorts, approximately one-third of eligible patients are actually enrolled at those CHSS member institutions that are actively enrolling patients in a given study, and approximately 10% to 15% of potentially eligible patients are enrolled across the entire CHSS. This analysis of available data suggests that opportunities exist to improve enrollment in CHSS studies. Determination of the denominator of patients eligible for CHSS studies and comparison of ''eligible and enrolled patients'' to ''potentially eligible and not enrolled patients'' provide an estimate of the extent to which patients in CHSS studies are representative of the overall population of eligible patients. The STS-CHSS Link has facilitated analyses not feasible with either database alone. The limitations of the STS-CHSS Link have been described previously. 1 The STS-CHSS Link can address the major weaknesses of each database. The major weakness of the STS-CHSD is its lack of information about longitudinal follow-up and long-term outcomes. Follow-up information in the STS National Database is currently collected for two short-term end points: (1) status at discharge from the hospital after surgery and (2) status 30 days after surgery. The major weakness of the CHSS-D is its voluntary enrollment and the associated inherent unlikelihood that this method will capture all eligible patients. Furthermore, although the CHSS has 74 North American member institutions, participation in CHSS research studies is voluntary and not all member institutions participate in CHSS studies. Therefore, the potential denominator of eligible patients for any given CHSS protocol is not known. Furthermore, there has never before been a mechanism to estimate the extent to which the enrolled patients are representative of the entire population of patients potentially eligible for CHSS studies, a concept that has potential ramifications regarding the generalizability of inferences drawn from studies of CHSS cohorts. The STS-CHSS Link provides a reasonable estimate of the denominator of patients eligible for CHSS studies and provides an estimate of the representativeness of CHSS enrolled patients with respect to the parameters that were analyzed. Because the STS-CHSD does not currently allow for longitudinal follow-up, the CHSS-D can allow for longitudinal follow-up of select cohorts of interest.
Future Directions
Ideally, the creation of the STS-CHSS Link will help to bring about increased enrollment in CHSS studies. Beginning with the Fall 2013 STS-CHSD feedback report, every six months, STS-CHSD participants will receive a list of the registry record numbers of all patients identified as potentially eligible for CHSS studies over the previous four years, using a rolling four-year time window (see Table 6 of Part 1 of this series of articles 1 ). In addition, every six months, STS-CHSD participants will receive a comparison of their own institution's enrolled patients with their own institution's potentially eligible but nonenrolled patients from STS. This comparison will be similar to Tables 3 to 10 of this current article but will only compare enrolled patients with potentially eligible nonenrolled patients at a given institution. Another ultimate goal of the STS-CHSS Link is not only to identify patients who are potentially eligible for CHSS studies but also to eliminate the duplication of effort involved in data collection for both STS-CHSD and CHSS-D. In the future, it is hoped that a system can be created where all of the basic data collected for STS-CHSD will immediately populate the CHSS data set. Creation of such a system will minimize the burden of entering data and make it possible that a single act of data entry can populate both the STS-CHSD and the CHSS-D. Such a system will be facilitated and enhanced by using the international nomenclature used in the STS-CHSD (The International Pediatric and Congenital Cardiac Code [http://www.ipccc.net/]) 1 at the time of inception of new CHSS cohorts when developing inclusionary and exclusionary criteria. If all of the basic data collected for STS-CHSD immediately populated the CHSS-D, CHSS could then send the partially completed data set derived from STS-CHSD to a center's data manager, pointing out what additional data is required.
Conclusion
The CHSS-D has been successfully linked to the STS-CHSD. Algorithms have been developed for all five active CHSS protocols to identify patients in STS-CHSD who are eligible for CHSS studies. Determination of the denominator of patients eligible for CHSS studies and comparison of ''eligible and enrolled patients'' to ''eligible and not enrolled patients'' provides an estimate of the extent to which patients in CHSS studies are representative of the overall population of eligible patients; however, opportunities exist to improve enrollment.
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